TROG Cancer Research
Members Login   CQMS Login

TROG 17.06 (SC24)

Primary sponsor: Canadian Cancer Trials Group (CCTG)
Collaborating group: Trans Tasman Radiation Oncology Group (TROG)


A Randomized Phase III Study Comparing Stereotactic Body Radiotherapy (SBRT) Versus Conventional Palliative Radiotherapy (CRT) for Patients With Spinal Metastases


This study aims to find out if SBRT is better than CRT at controlling pain in the spine 3 months after receiving treatment.

Participating Centres

Current participating centres

Trial Status 

Closed to accrual September 2019

Final Accrual

229 (international)

24 (TROG)

Current Accrual Graph

Current accrual graph

Trial chairpersons

A/Prof Shankar Siva, Peter MacCallum Cancer Centre
A/Prof Matthew Foote, Princess Alexandra Hospital

Trial contact

Rebecca Montgomery
Trial Coordinator
TROG Trial Coordinating Centre
Phone: +61 2 4014 3910

Trial resources for TROG members

TROG 17.06 member page

We are thankful to our 14,500 patients who have participated in our research. Please continue the generous support.